Flow Therapy is offering Enhanced External Counterpulsation, or EECP, to treat patients with Long COVID symptoms.
EECP Therapy is a noninvasive outpatient treatment for symptoms associated with heart disease. These symptoms are typically caused by a lack of blood supply to the heart, causing angina, shortness of breath, fatigue, and/or a decreased ability to exercise and engage in activities of daily living. EECP Therapy is believed to increase blood flow and oxygen to the heart and other organs, reducing or eliminating these symptoms in most patients.